ArticleBritish journal of clinical pharmacology2026

The interplay of GLP-1 receptor agonist use, chronic kidney disease and fracture risk in obese pAtients: a retrospective cohort study.

Amari Eubanks et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.